UFP Technologies (FRA:UFP) Cyclically Adjusted Revenue per Share: €37.99 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:UFP UFP Technologies Inc FRA:UFP
96 GF Score
Price €207.20
GF Value €236.49
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is UFP Technologies Cyclically Adjusted Revenue per Share?

UFP Technologies FRA:UFP -4.69% 96 Cyclically Adjusted Revenue per Share is €37.99 as of Mar. 2026. GuruFocus rates FRA:UFP with a GF Score™ of 96/100 and a GF Value™ of €236.49 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

UFP Technologies's adjusted revenue per share for the three months ended in Mar. 2026 was €17.103. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €37.99 for the trailing ten years ended in Mar. 2026.

During the past 12 months, UFP Technologies's average Cyclically Adjusted Revenue Growth Rate was 16.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of UFP Technologies was 14.70% per year. The lowest was 1.50% per year. And the median was 4.40% per year.

As of today (2026-07-14), UFP Technologies's current stock price is €207.20. UFP Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €37.99. UFP Technologies's Cyclically Adjusted PS Ratio of today is 5.45.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of UFP Technologies was 10.37. The lowest was 1.18. And the median was 2.51.


UFP Technologies  (FRA:UFP) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

UFP Technologies's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=207.20/37.99
=5.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of UFP Technologies was 10.37. The lowest was 1.18. And the median was 2.51.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


UFP Technologies Cyclically Adjusted Revenue per Share Related Terms


UFP Technologies Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for UFP Technologies's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UFP Technologies Cyclically Adjusted Revenue per Share Chart

UFP Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.07 26.49 29.63 35.85 38.78

UFP Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.21 34.57 35.67 38.78 37.99

FRA:UFP vs NEOG, ALMR, NVCR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, UFP Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UFP Technologies Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where UFP Technologies's Cyclically Adjusted PS Ratio falls into.


FRA:UFP
96GF Score
UFP Technologies Inc FRA:UFP
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UFP Technologies Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, UFP Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=17.103/330.2130*330.2130
=17.103

Current CPI (Mar. 2026) = 330.2130.

UFP Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 4.653 241.018 6.375
201609 4.554 241.428 6.229
201612 4.738 241.432 6.480
201703 4.748 243.801 6.431
201706 4.605 244.955 6.208
201709 4.072 246.819 5.448
201712 4.267 246.524 5.716
201803 4.719 249.554 6.244
201806 5.660 251.989 7.417
201809 5.511 252.439 7.209
201812 5.940 251.233 7.807
201903 5.610 254.202 7.287
201906 6.092 256.143 7.854
201909 5.986 256.759 7.698
201912 5.924 256.974 7.612
202003 5.796 258.115 7.415
202006 5.028 257.797 6.440
202009 4.866 260.280 6.173
202012 4.864 260.474 6.166
202103 5.393 264.877 6.723
202106 5.552 271.696 6.748
202109 5.675 274.310 6.832
202112 6.472 278.802 7.665
202203 8.478 287.504 9.737
202206 11.731 296.311 13.073
202209 12.823 296.808 14.266
202212 11.092 296.797 12.341
202303 11.887 301.836 13.005
202306 12.007 305.109 12.995
202309 12.250 307.789 13.142
202312 12.067 306.746 12.990
202403 12.486 312.332 13.201
202406 13.202 314.175 13.876
202409 16.829 315.301 17.625
202412 17.525 315.605 18.336
202503 17.623 319.799 18.197
202506 16.862 322.561 17.262
202509 16.926 324.800 17.208
202512 16.165 324.054 16.472
202603 17.103 330.213 17.103

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €37.99 mean?
UFP Technologies (FRA:UFP) has a Cyclically Adjusted Revenue per Share of €37.99 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on UFP Technologies and its competitors.
Is UFP Technologies' Cyclically Adjusted Revenue per Share too high?
UFP Technologies' current Cyclically Adjusted Revenue per Share is €37.99. Overall, UFP Technologies has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UFP Technologies' Cyclically Adjusted Revenue per Share compare to NEOG and ALMR?
UFP Technologies' Cyclically Adjusted Revenue per Share of €37.99 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on UFP Technologies and its competitors. UFP Technologies's current Cyclically Adjusted Revenue per Share is €37.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UFP Technologies stock overvalued right now?
Based on GuruFocus' analysis, UFP Technologies (FRA:UFP) is currently considered Modestly Undervalued. The stock's GF Value™ is €236.49, compared to a current price of €207.20 — trading 12.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €37.99. UFP Technologies' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For UFP Technologies (FRA:UFP), the current Cyclically Adjusted Revenue per Share is €37.99 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UFP Technologies (FRA:UFP) Overvalued in 2026?

Based on GuruFocus' analysis, UFP Technologies stock appears to be undervalued. The current stock price of €207.20 is trading 12.4% below its estimated GF Value™ of €236.49. GuruFocus considers UFP Technologies to be Modestly Undervalued.

Key valuation signals for FRA:UFP:

  • Cyclically Adjusted Revenue per Share: €37.99
  • GF Value™: €236.49 vs. price of €207.20 (12.4% below fair value)
  • GF Score™: 96/100 with 2 warning signs

No single metric tells the full story. See the FRA:UFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


UFP Technologies Business Description

Other Exchanges UFPT:USA
Address 100 Hale Street, Newburyport, MA, USA, 01950-3504
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
96GF Score

Get the complete analysis for FRA:UFP

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€207.20
Price
€236.49
GF Value